Faller A - Search Results

1

Selective inhibition of low affinity IgE receptor (CD23) processing: P1' bicyclomethyl substituents.

Bailey S, Bolognese B, Faller A, Louis-Flamberg P, MacPherson DT, Mayer RJ, Marshall LA, Milner PH, Mistry J, Smith DG, Ward JG. Bailey S, et al. Among authors: faller a. Bioorg Med Chem Lett. 1999 Nov 1;9(21):3165-70. doi: 10.1016/s0960-894x(99)00552-1. Bioorg Med Chem Lett. 1999. PMID: 10560745

2

Hydroxamate-based inhibitors of low affinity IgE receptor (CD23) processing.

Bailey S, Bolognese B, Buckle DR, Faller A, Jackson S, Louis-Flamberg P, McCord M, Mayer RJ, Marshall LA, Smith DG. Bailey S, et al. Among authors: faller a. Bioorg Med Chem Lett. 1998 Jan 6;8(1):23-8. doi: 10.1016/s0960-894x(97)10148-2. Bioorg Med Chem Lett. 1998. PMID: 9871622

3

Selective inhibition of low affinity IgE receptor (CD23) processing.

Bailey S, Bolognese B, Buckle DR, Faller A, Jackson S, Louis-Flamberg P, McCord M, Mayer RJ, Marshall LA, Smith DG. Bailey S, et al. Among authors: faller a. Bioorg Med Chem Lett. 1998 Jan 6;8(1):29-34. doi: 10.1016/s0960-894x(97)10149-4. Bioorg Med Chem Lett. 1998. PMID: 9871623

4

Inhibition of CD23 processing correlates with inhibition of IL-4-stimulated IgE production in human PBL and hu-PBL-reconstituted SCID mice.

Mayer RJ, Bolognese BJ, Al-Mahdi N, Cook RM, Flamberg PL, Hansbury MJ, Khandekar S, Appelbaum E, Faller A, Marshall LA. Mayer RJ, et al. Among authors: faller a. Clin Exp Allergy. 2000 May;30(5):719-27. doi: 10.1046/j.1365-2222.2000.00812.x. Clin Exp Allergy. 2000. PMID: 10792365

5

CD23 shedding: requirements for substrate recognition and inhibition by dipeptide hydroxamic acids.

Mayer RJ, Flamberg PL, Katchur SR, Bolognese BJ, Smith DG, Marolewski AE, Marshall LA, Faller A. Mayer RJ, et al. Among authors: faller a. Inflamm Res. 2002 Feb;51(2):85-90. doi: 10.1007/BF02684008. Inflamm Res. 2002. PMID: 11926319 Review.

6

Relaxant activity of 6-cyano-2,2-dimethyl-2H-1-benzopyran-4-carboxamides and -thiocarboxamides and their analogues in guinea pig trachealis.

Arch JR, Buckle DR, Carey C, Parr-Dobrzanski H, Faller A, Foster KA, Houge-Frydrych CS, Pinto IL, Smith DG, Taylor SG. Arch JR, et al. Among authors: faller a. J Med Chem. 1991 Aug;34(8):2588-94. doi: 10.1021/jm00112a037. J Med Chem. 1991. PMID: 1875351

7

BACE-1 inhibitors part 3: identification of hydroxy ethylamines (HEAs) with nanomolar potency in cells.

Beswick P, Charrier N, Clarke B, Demont E, Dingwall C, Dunsdon R, Faller A, Gleave R, Hawkins J, Hussain I, Johnson CN, MacPherson D, Maile G, Matico R, Milner P, Mosley J, Naylor A, O'Brien A, Redshaw S, Riddell D, Rowland P, Skidmore J, Soleil V, Smith KJ, Stanway S, Stemp G, Stuart A, Sweitzer S, Theobald P, Vesey D, Walter DS, Ward J, Wayne G. Beswick P, et al. Among authors: faller a. Bioorg Med Chem Lett. 2008 Feb 1;18(3):1022-6. doi: 10.1016/j.bmcl.2007.12.020. Epub 2007 Dec 15. Bioorg Med Chem Lett. 2008. PMID: 18171615

8

BACE-1 inhibitors part 2: identification of hydroxy ethylamines (HEAs) with reduced peptidic character.

Clarke B, Demont E, Dingwall C, Dunsdon R, Faller A, Hawkins J, Hussain I, MacPherson D, Maile G, Matico R, Milner P, Mosley J, Naylor A, O'Brien A, Redshaw S, Riddell D, Rowland P, Soleil V, Smith KJ, Stanway S, Stemp G, Sweitzer S, Theobald P, Vesey D, Walter DS, Ward J, Wayne G. Clarke B, et al. Among authors: faller a. Bioorg Med Chem Lett. 2008 Feb 1;18(3):1017-21. doi: 10.1016/j.bmcl.2007.12.019. Epub 2007 Dec 15. Bioorg Med Chem Lett. 2008. PMID: 18166458

9

BACE-1 inhibitors part 1: identification of novel hydroxy ethylamines (HEAs).

Clarke B, Demont E, Dingwall C, Dunsdon R, Faller A, Hawkins J, Hussain I, MacPherson D, Maile G, Matico R, Milner P, Mosley J, Naylor A, O'Brien A, Redshaw S, Riddell D, Rowland P, Soleil V, Smith KJ, Stanway S, Stemp G, Sweitzer S, Theobald P, Vesey D, Walter DS, Ward J, Wayne G. Clarke B, et al. Among authors: faller a. Bioorg Med Chem Lett. 2008 Feb 1;18(3):1011-6. doi: 10.1016/j.bmcl.2007.12.017. Epub 2007 Dec 15. Bioorg Med Chem Lett. 2008. PMID: 18171614

10

Structure-activity relationship of hydroxamate-based inhibitors on the secretases that cleave the amyloid precursor protein, angiotensin converting enzyme, CD23, and pro-tumor necrosis factor-alpha.

Parkin ET, Trew A, Christie G, Faller A, Mayer R, Turner AJ, Hooper NM. Parkin ET, et al. Among authors: faller a. Biochemistry. 2002 Apr 16;41(15):4972-81. doi: 10.1021/bi015936e. Biochemistry. 2002. PMID: 11939793

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

120 results

Search Page

Filters